,
Bock, Christoph https://orcid.org/0000-0001-6091-3088
Halbritter, Florian
Carmona, Francisco J
Tierling, Sascha
Datlinger, Paul
Assenov, Yassen
Berdasco, María
Bergmann, Anke K
Booher, Keith
Busato, Florence
Campan, Mihaela
Dahl, Christina
Dahmcke, Christina M
Diep, Dinh
Fernández, Agustín F
Gerhauser, Clarissa
Haake, Andrea
Heilmann, Katharina
Holcomb, Thomas
Hussmann, Dianna
Ito, Mitsuteru
Kläver, Ruth
Kreutz, Martin
Kulis, Marta
Lopez, Virginia
Nair, Shalima S
Paul, Dirk S
Plongthongkum, Nongluk
Qu, Wenjia
Queirós, Ana C
Reinicke, Frank
Sauter, Guido
Schlomm, Thorsten
Statham, Aaron
Stirzaker, Clare
Strogantsev, Ruslan
Urdinguio, Rocío G
Walter, Kimberly
Weichenhan, Dieter
Weisenberger, Daniel J
Beck, Stephan
Clark, Susan J
Esteller, Manel
Ferguson-Smith, Anne C
Fraga, Mario F
Guldberg, Per
Hansen, Lise Lotte
Laird, Peter W
Martín-Subero, José I
Nygren, Anders O H
Peist, Ralf
Plass, Christoph
Shames, David S
Siebert, Reiner
Sun, Xueguang
Tost, Jörg
Walter, Jörn
Zhang, Kun
Article History
Received: 14 June 2015
Accepted: 10 May 2016
First Online: 27 June 2016
Competing interests
: C.B. and P.D. are developers of a protocol for high-throughput RRBS (licensed to Diagenode); D.W. is a consultant for Zymo Research Corporation; K.B. and X.S. are paid employees of Zymo Research Corporation; P.G. is an inventor on a patent (EP1334209; US2004048275) on melting analysis of DNA methylation (licensed to QIAGEN); K.Z. is a co-founder of Singlera Genomics Inc.; T.H., K.W. and D.S.S. are paid employees of Genentech Inc. and hold company stocks; L.L.H. is an inventor on a patent on aspects of MS-HRM (US20090155791); R.K., M.Kr., F.R. and R.P. are paid employees of QIAGEN; S.B. is a member of the consortium that designed the Infinium 450k assay; A.N. is a paid employee of Agena Bioscience and holds company stock options.